Forbes Explores SPAC’s $32.6B Medicare Litigation Enterprise
June 1, 2022 Commercial, Deals, Premium

A new Medicare/Medicaid technology company is leveraging the fundamentals of litigation investment via SPAC, with billions of dollars on the line. MSP Recovery claims it differs from Omni Bridgeway and Burford Capital, in that the company funds and litigates its own cases. In turn, MSP’s focus is on a 50/50 split of awards received between itself and insurers who have overpaid Medicare/Medicaid expenses. MSP says it is sitting on a $1.5T portfolio, and forecasts $87B in recoverable claims.
Follow us on social mediaRelated



